A Critical Role of the IL-22-IL-22 Binding Protein Axis in Hepatocellular Carcinoma

Giannou, AD; Lucke, J; Kleinschmidt, D; Shiri, AM; Steglich, B; Nawrocki, M; Zhang, T; Zazara, DE; Kempski, J; Zhao, L; Giannou, O; Agalioti, T; Brockmann, L; Bertram, F; Sabihi, M; Bottcher, M; Ewald, F; Schulze, K; von Felden, J; Machicote, A; Maroulis, IC; Arck, PC; Grass, JK; Mercanoglu, B; Reeh, M; Wolter, S; Tachezy, M; Seese, H; Theodorakopoulou, M; Lykoudis, PM; Heumann, A; Uzunoglu, FG; Ghadban, T; Mann, O; Izbicki, JR; Li, J; Dupree, A; Melling, N; Gagliani, N; Huber, S

Giannou, AD; Huber, S (通讯作者),Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Sect Mol Immunol & Gastroenterol, D-20246 Hamburg, Germany.;Giannou, AD; Huber, S (通讯作者),Univ Med Ctr Hamburg Eppendorf, Hamburg Ctr Translat Immunol HCTI, D-20246 Hamburg, Germany.;Huber, S (通讯作者),Univ Med Ctr Hamburg Eppendorf, Dept Med 1, D-20246 Hamburg, Germany.

CANCERS, 2022; 14 (24):

Abstract

Simple Summary Hepatocellular carcinoma (HCC) still poses a major challenge for curative treatment. Although some new therapeutic options arose during......

Full Text Link